| The PRO-ACT database: design, initial analyses, and predictive features N Atassi, J Berry, A Shui, N Zach, A Sherman, E Sinani, J Walker, ... Neurology 83 (19), 1719-1725, 2014 | 242 | 2014 |
| Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression R Küffner, N Zach, R Norel, J Hawe, D Schoenfeld, L Wang, G Li, L Fang, ... Nature biotechnology 33 (1), 51-57, 2015 | 198 | 2015 |
| Predicting disease progression in amyotrophic lateral sclerosis AA Taylor, C Fournier, M Polak, L Wang, N Zach, M Keymer, JD Glass, ... Annals of clinical and translational neurology 3 (11), 866-875, 2016 | 65 | 2016 |
| Emergence of novel representations in primary motor cortex and premotor neurons during associative learning N Zach, D Inbar, Y Grinvald, H Bergman, E Vaadia Journal of Neuroscience 28 (38), 9545-9556, 2008 | 62 | 2008 |
| Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis T Fekete, N Zach, LR Mujica-Parodi, MR Turner PloS one 8 (12), e85190, 2013 | 56 | 2013 |
| Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach R Kueffner, N Zach, M Bronfeld, R Norel, N Atassi, V Balagurusamy, ... Scientific reports 9 (1), 690, 2019 | 53 | 2019 |
| Being PRO-ACTive: what can a clinical trial database reveal about ALS? N Zach, DL Ennist, AA Taylor, H Alon, A Sherman, R Kueffner, J Walker, ... Neurotherapeutics 12, 417-423, 2015 | 42 | 2015 |
| Precompetitive consensus building to facilitate the use of digital health technologies to support Parkinson disease drug development through regulatory science D Stephenson, R Alexander, V Aggarwal, R Badawy, L Bain, R Bhatnagar, ... Digital Biomarkers 4 (Suppl. 1), 28-49, 2020 | 36 | 2020 |
| Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation M Haas, D Stephenson, K Romero, MF Gordon, N Zach, H Geerts, ... Alzheimer's & Dementia 12 (9), 1022-1030, 2016 | 34 | 2016 |
| Challenges: crowdsourced solutions E Bender Nature 533 (7602), S62-S64, 2016 | 34 | 2016 |
| Laquinimod treatment improves myelination deficits at the transcriptional and ultrastructural levels in the YAC128 mouse model of Huntington disease M Garcia-Miralles, NABM Yusof, JY Tan, CI Radulescu, H Sidik, LJ Tan, ... Molecular neurobiology 56, 4464-4478, 2019 | 33 | 2019 |
| Item response theory analysis of the amyotrophic lateral sclerosis functional rating scale-revised in the pooled resource open-access ALS clinical trials database ED Bacci, D Staniewska, KS Coyne, S Boyer, LA White, N Zach, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (3-4), 157-167, 2016 | 27 | 2016 |
| Segregation between acquisition and long‐term memory in sensorimotor learning N Zach, N Kanarek, D Inbar, Y Grinvald, T Milestein, E Vaadia European journal of neuroscience 22 (9), 2357-2362, 2005 | 25 | 2005 |
| Qualitative measures that assess functional disability and quality of life in ALS SL Hartmaier, T Rhodes, SF Cook, C Schlusser, C Chen, S Han, N Zach, ... Health and Quality of Life Outcomes 20 (1), 12, 2022 | 16 | 2022 |
| Epidemiology of amyotrophic lateral sclerosis: a population-based study in Israel C Weil, N Zach, S Rishoni, V Shalev, G Chodick Neuroepidemiology 47 (2), 76-81, 2016 | 16 | 2016 |
| Single neurons in M1 and premotor cortex directly reflect behavioral interference N Zach, D Inbar, Y Grinvald, E Vaadia PLoS One 7 (3), e32986, 2012 | 14 | 2012 |
| Being in time: Dynamical models of phenomenal experience S Edelman, T Fekete, N Zach John Benjamins Publishing, 2012 | 12 | 2012 |
| Design and analysis of a clinical trial using previous trials as historical control DA Schoenfeld, DM Finkelstein, E Macklin, N Zach, DL Ennist, AA Taylor, ... Clinical Trials 16 (5), 531-538, 2019 | 11 | 2019 |
| Being in time S Edelman, N Zach, T Fekete Being in Time, 1-277, 2012 | 10 | 2012 |
| ALSUntangled No. 30: Methylcobalamin ALSUntangled Group Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (7-8), 536-539, 2015 | 9 | 2015 |
Merit CudkowiczProfessor of Neurology, Harvard Medical SchoolBestätigte E-Mail-Adresse bei mgh.harvard.edu
